Friday, April 15, 2022

bluebird's beti-cel good value at $2.1 million, ICER says - The Pharma Letter

Also known as Zynteglo, this gene therapy won European approvals but bluebird has since withdrawn from the European market following failed ...

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...